New cGMP fermentation facility in the UK set to meet growing demand for drug substance production, supporting biopharma ...

The interim phase 2 trial results show a good immune response in participants and the therapy is well tolerated to date.

The Series D financing will support the clinical development of two ADCs.

Emraclidine was expected to be a competitor to Bristol Myers Squibb’s recently approved Cobenfy, but trial results put its ...

The FDA had put a clinical hold on Novavax’s COVID-19-influenza combo vaccine after an adverse event in a patient.

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

The U.S. company Aditum Bio and Chinese company Leads Biolabs today announced that they have founded Oblenio Bio, a new ...

The Dutch biotech Synaffix and the Swiss company BigHat Biosciences announced yesterday that they have entered into a ...

The U.S. contract development and manufacturing organization (CDMO) Abzena announced yesterday that it has significantly ...

The US biopharma will discontinue development of the Exondys 51 (eteplirsen) follow up treatment to focus on other treatment ...

UK-based private biotech company Ottimo Pharma has emerged from stealth mode after four years with the appointment of a ...